Abstract:Objective To explore the clinical efficacy of 3D laparoscopic radical anterograde modular pancreaticosplenectomy (LRAMPS) in the treatment of pancreatic body and tail cancer.Methods A retrospective analysis was conducted on the clinical data of 22 patients who underwent 3D LRAMPS from January 2023 to December 2024. The operation time, intraoperative blood loss, time to get out of bed for the first time after surgery, hospital stay, postoperative exhaust time, postoperative complications, pathological types, follow-up situation and recurrence situation were statistically analyzed.Results All patients successfully completed the surgery under 3D laparoscopy. The operation time was (263.6 ± 20.5) min, the intraoperative blood loss was (100.4 ± 30.5) mL, the first time to get out of bed after the operation was (1.5 ± 0.5) d, the hospital stay was (8.5 ± 2.1) d, and the postoperative exhaust time was (2.5 ± 1.0) d. There were 10 cases of grade A pancreatic fistula and 6 cases of grade B pancreatic fistula after the operation (all recovered and were discharged after adequate drainage, anti-infection and other treatments), and no grade C pancreatic fistula occurred. There were no cases of postoperative massive hemorrhage or perioperative death. Postoperative pathological reports showed that there were 17 cases of pancreatic ductal adenocarcinoma, 3 cases of pancreatic cystadenocarcinoma, and 2 cases of neuroendocrine carcinoma. All patients underwent R0 resection, and (15.1 ± 4.3) lymph nodes were dissected. Lymph node examinations were positive in 8 patients, with a positive rate of 36.4%. The postoperative follow-up period ranged from 4~19 months, with a median follow-up time of 12 (5.5, 16.5) months. There were 2 cases of recurrence.Conclusion 3D LRAMPS for pancreatic body and tail cancer is a safe, effective and minimally invasive treatment method. Hospitals with rich experience in laparoscopic surgery can try to carry it out.